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Expression of Matrix Metalloproteinase-2 and -13 and Tissue 
Inhibitor of Metalloproteinase-4 in Varicose Veins
Jee  Won  Chang,  M.D.*,  Young-Hee  Maeng,  M.D.**,  Su  Wan  Kim,  M.D.*
Background:  The relationship between the degree of expression of matrix metalloproteinases or tissue inhibitor of 
metalloproteinases and venous reflux remains to be investigated. Materials and Methods: Primary varicose vein 
tissues were obtained from 23 patients, 18 females and 5 males, aged from 19 to 73. Cephalic or basilic veins 
were obtained for the control group from 10 patients who underwent vascular access for maintenance hemodialysis. 
Two operative techniques (high ligation with stripping or endovenous laser coagulation) were used. The expression 
of matrix metalloproteinase-2 and 13 and tissue inhibitor of metalloproteinase-4 in the varicose vein group and con-
trol group was assessed semi-quantitatively by immunohistochemical slides stained with primary antibodies. Results: 
Twenty (87%) of the varicose vein group patients had greater or lesser saphenous vein diseases with reflux. The 
focal weak (＋) stain for matrix metalloproteinases-2, and 13, and tissue inhibitor of matrix metalloproteinase-4 was 
dominant in the varicose vein group; the focal or diffuse strong stain (＋＋ or  ＋＋＋) was prevalent in the con-
trol group. The differences were statistically significant (p＜0.01). The degree of reflux and the duration of symp-
toms were not significantly related to the expression of MMP-13 (p=0.317 and p=0.654, respectively). Conclusion: 
Further study should be performed to investigate the relationship between the clinical characteristics related to ve-
nous hypertension or reflux and expression of MMPs and TIMP in varicose veins.
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INTRODUCTION
Reflux,  or  pathologic  retrograde  flow,  caused  by  an  in-
competent venous valve has been reported as one of the most 
important etiologic factors of varicose veins (VV) in the low-
er  extremities.  Furthermore,  venous  hypertension  followed  by 
reflux can cause changes in the physical properties of the ve-
nous  walls  by  increased  expression  of  matrix  metallopro-
teinases  (MMPs),  which  will  lead  to  a  dilated  and  serpentine 
morphology  of  VV  [1].  However,  the  relationship  between 
venous  hypertension  or  reflux  and  the  expression  of  various 
subtypes of MMPs, or role of each subtype of MMPs, in cre-
ating  morphologic  changes  is  still  controversial  [2].  This 
study  is  focused  on  comparing  the  level  of  expression  of 
MMP-2,  MMP-13,  and  tissue  inhibitor  of  metalloproteinase-4 
(TIMP-4) between VV and non-varicose veins in order to in-
vestigate  the  relationship  between  the  expression  of  MMPs 
and  the  clinical  characteristics  related  to  reflux  in  VV.Jee Won Chang, et al
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Table 1. Patient characteristics based on the classification of 
chronic venous disease (n=23)
C  (clinical  signs)
C0 ( n o  v i s i b l e  o r  p a l p a b l e  s i n g s  o f  v e n o u s  
disease)   
C1  (telangiectasias,  reticular  veins,  malleolar 
flare)
C2 ( v a r i c o s e  v e i n s )
C3  (edema  without  skin  changes)
C4  (skin  changes  ascribed  to  venous  disease 
e.g.,  pigmentation,  venous  eczema, 
lipodermatosclerosis)
C5 ( s k i n  c h a n g e s  a s  d e f i n e d  a b o v e  w i t h  h e a l e d  
ulceration)
C6 ( s k i n  c h a n g e s  a s  d e f i n e d  a b o v e  w i t h  a c t i v e  
ulceration)
E  (etiology)
Ep ( p r i m a r y )
Es  (secondary)
Ec  (congenital)
A  (anatomic  distribution),  As1-5  superficial  veins
As1  (telangiectasias/reticular  veins)
As2  (greater  saphenous  vein,  above-knee)
As3  (greater  saphenous  vein,  below-knee)
As4  (lesser  saphenous  vein)
As5  (nonsaphenous)
P  (pathophysiology)
PR  (reflux)
Po  (obstruction)
None  of  the  above
0
0
15
 3
 5
 0
 0
23 
 0
 0
 0
 0
15
 5
 3
20
 0
 3
MATERIALS AND METHODS
Twenty-three  patients  who  underwent  surgery  for  primary 
varicose  veins  from  October  2009  to  February  2010  were 
included.  Informed  consent  was  obtained  from  all  the  pa-
tients,  and  this  study  was  approved  by  Institutional  Review 
Board  of  Jeju  National  University  Hospital.  The  specimens 
used  from  the  control  group  of  patients  (n=10)  who  under-
went  surgery  for  vascular  access  formation  for  maintenance 
hemodialysis,  were  cephalic  or  basilica  veins.  None  of  the 
control  group  patients  had  varicose  veins  in  their  lower 
extremities.
The mean age of the patients with VV was 52.5 (range 19
∼73)  and  78.3%  (n=18)  were  female.  The  patients’  charac-
teristics  based  on  the  classification  of  chronic  venous  disease 
in  the  “Reporting  standards  in  venous  disease”  [3]  are  pre-
sented  in  Table  1.
Symptoms,  cosmetic  needs,  or  concerns  about  complica-
tions  were  treated  by  surgical  resection.  A  careful  medical 
history,  physical  examination,  and  routine  preoperative  labo-
ratory studies were performed for each patient, and duplex ul-
trasonography  of  deep  and  superficial  veins  of  the  legs  was 
performed  in  order  to  rule  out  secondary  varicose  veins  and 
detect  venous  reflux.  Two  operative  techniques  for  VV  were 
used: high ligation with stripping and endovenous laser coag-
ulation  with  an  810  nm  diode  laser  (Dinona  Inc.,  Daejeon, 
South  Korea)  with  or  without  additional  individual  ligation 
and  excision.  In  cases  of  severely  tortuous  and  dilated  VV, 
high ligation and stripping was preferred because the insertion 
and  progression  of  the  laser  catheter  can  be  difficult  and  in-
complete  obliteration  or  recurrence  should  be  prevented.  In 
the cases in which no clear differences between the two tech-
niques  were  predicted,  one  of  the  techniques  was  selected 
based  on  the  patient’s  preference.
Immunohistochemical  analysis  for  the  expression  of  the 
M M P s  a n d  T I M P - 4  w a s  p e r f o r m e d  a s  f o l l o w s .  T e n  p e r c e n t  
formalin-fixed,  paraffin-embedded  tissue  was  cut  at  4  μm 
slices,  deparaffinized  in  xylene,  and  rehydrated  with  graded 
ethanol.  A  standard  immunohistochemical  technique  was  per-
formed  using  a  Ventana  BenchMark  XT  immunostainer 
(Ventana  Medical  Systems  Inc.,  AZ,  USA).  Heat  epitope  re-
trieval  provided  by  the  immunostainer  was  performed  for  60 
minutes.  The  enzymatic  reactivity  was  visualized  with 
3,3’-diaminobenzidine.  The  prim a r y  a n t i b o d i e s  u s e d  w e r e  a n -
ti-MMP-2  (Diagnostic  BioSystems,  California,  USA;  clone 
A-Gel VC2; dilution 1 : 25), anti-MMP-13 (American Diagno-
stica  inc.,  Connecticut,  USA;  polyclonal;  1 : 50),  and  an-
ti-TIMP-4  (Diagnostic  BioSystems,  California,  USA;  poly-
clonal;  dilution  1 : 50).  They  were  diluted  with  PBS  buf-
fer-based  dilution  solution  and  incubated  for  32  minutes  at 
37
oC.  For  the  negative  controls,  the  slides  were  stained  by 
omitting  the  primary  antibody  from  the  protocol  and  sub-
stituting  it  with  commercially  available  nonimmune  mouse 
immunoglobulin  G  serum  (DAKO,  Carpinteria,  CA,  USA).   
The  immunohistochemical  slides  were  evaluated  and  in-
terpreted by a pathologist. The slides were scored semi-quan-
titatively  for  staining  intensity  and  quantity  as  follows:  -  no 
signal detectable, ＋ focal weak staining, ＋＋ focal (＜50%) Expression of MMP-2 and 13 and TIMP-4 in Varicose Veins
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Fig. 1. Photomicrographs show immunohistochemical findings of MMP2 (A: ＋, B: ＋＋＋), MMP13 (C: ＋, D: ＋＋＋), and TIMP4 (E: ＋, 
F: ＋＋＋) in the vascular wall (×40). MMP=Matrix metalloproteinase; TIMP=Tissue inhibitor of metalloproteinase.
Table 2. Preoperative clinical characteristics (n=23) 
Symptoms*
Fatigue  of  legs
Heaviness
Burning  sensation  or  itching
Pain
Night  cramp
Duration  of  symptoms
Less  than  1  year
1  year∼3  years
3  years∼5  years
Longer  than  5  years
Grade  of  reflux  on  duplex  ultrasonography 
＋
＋＋
＋＋＋
＋＋＋＋
13
 7
 2
 8
10
0
12
8
3
3
6
9
2
*Each  patient  presented  more  than  one  symptom.
strong or diffuse (≥50%) weak staining, and ＋＋＋ diffuse 
strong  staining  (Fig.  1). 
A  Pearson  chi  squared  test  (SPSS,  version  12.1  for 
Windows,  Chicago,  IL,  USA)  was  used  for  determining  the 
differences  in  expression  between  MMPs  and  TIMP-4;  a 
p-value  ＜0.05  was  considered  statistically  significant.   
RESULTS
The  patients’  clinical  characteristics  including  their  symp-
toms,  the  duration  of  symptoms,  and  grade  of  reflux  on  du-
plex ultrasonography are presented in Table 2. Twenty (87%) 
patients  had  greater  or  lesser  saphenous  vein  disease  with 
reflux.  Ligation  of  the  sapheno-femoral  or  sapheno-popliteal 
junction with stripping was performed for 17 patients and en-
dovenous  laser  coagulation  with  additional  individual  ex-
cisions  was  performed  for  6  patients.
Immunohistochemical  analysis  showed  that  focal  or  diffuse 
strong  staining  for  MMP-2  and  MMP-13  tended  to  be  prom-
inent  in  the  control  group,  whereas  focal  weak  staining  was 
prevalent  in  the  disease  group  (Table  3).  No  specimen 
showed  diffuse  strong  staining  for  MMP-2  in  the  varicose 
vein group. Expression of TIMP-4 also showed a similar pat-
tern  to  that  of  MMPs.  Half  (n=5)  of  the  control  group 
showed  diffuse  strong  staining  for  TIMP-4,  but  strong  stain-Jee Won Chang, et al
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Table 3. Differences in expression of MMPs and TIMP between the disease group and the control group
MMP-2 MMP-13 TIMP-4
Disease Control Disease Control Disease Control
＋＋＋
＋＋ 
＋
Total
0  (0%)
  1  (4.3%)
  22  (95.7%)
  23  (100%)
5  (50%)
2  (20%)
3  (30%)
10  (100%)
1  (4.4%)
  9  (39.1%)
13  (56.5%)
23  (100%)
  9  (90%)
  1  (10%)
0  (0%)
  10  (100%)
0  (0%)
  12  (52.2%)
  11  (47.8%)
  23  (100%)
5  (50%)
2  (20%)
3  (30%)
10  (100%)
MMP=Matrix  metalloproteinase;  TIMP=Tissue  inhibitor  of  metalloproteinase.
Table 4. Expression of MMP-13 according to the duration of 
symptoms or reflux
MMP-13
＋＋ or 
＋＋＋ (n=12)
MMP-13
＋ (n=11)
Reflux 
＋＋ or  ＋＋＋
Reflux
＋
Duration 
Less  than  3  years  (n=12)
Duration
Longer  than  4  years  (n=11)
7
5
6
6
6
5
6
5
MMP=Matrix  metalloproteinases.
ing  for  TIMP-4  in  the  varicose  vein  group  was  not 
indentified.  When  focal  or  diffuse  strong  staining  (＋＋ or 
＋＋＋)  is  considered  to  identify  a  ‘significantly  stained 
g r o u p ’  a n d  f o c a l  w e a k  s t a i n  ( ＋)  is  considered  to  identify  a 
‘group that is not significantly stained’, the differences in the 
expression  of  MMP-2,  MMP-13,  and  TIMP-4  between  the 
disease and the control groups were all statistically significant 
(p＜0.001). 
The  relationship  between  the  degree  of  reflux  observed  on 
the  duplex  ultrasonography  or  the  duration  of  symptoms  and 
expression  of  MMP-13  is  presented  in  Table  4,  and  there  is 
no  significant  increase  in  expression  of  MMP-13  with  a  rise 
in  the  degree  of  reflux  or  a  longer  duration  of  symptoms 
(p=0.317  and  p=0.654,  respectively). 
DISCUSSION
The etiologic factors causing structural changes observed in 
VV remain to be clarified. Although venous hypertension fol-
lowed  by  valvular  incompetence  was  believed  to  be  the  pri-
mary  cause,  the  biochemical  or  molecular  mechanisms  con-
necting  venous  hypertension  and  structural  changes  are  still 
unclear. Vascular wall remodeling is reported to be related to 
the  activity  of  macrophages,  smooth  muscle  cells,  endothelial 
cells,  fibroblasts  [4],  MMPs,  the  enzymes secreted  by  macro-
phages,  collagen,  fibronectin,  laminin,  and  other  components 
of  the  extracellular  matrix.
It  was  initially  hypothesized  that  this  study  would  reveal 
the  increased  expression  of  MMP-2  and  -13  and  TIMP-4  in 
VV  because  most  of  the  studies  that  have  compared  the  ex-
pressions  of  MMPs  and  TIMPs  between  human  VV  and 
non-varicose vein specimens showed up-regulation of the var-
ious subtypes  of MMPs  [5]. Those results agree with the ex-
isting  hypothesis  that  morphologic  characteristics  of  VV  are 
caused  by  degradation  of  the  extracellular  matrix.  Further-
more, Raffetto and colleagues [6] reported that the magnitude 
and  the  duration  of  the  venous  wall  tension  in  vitro  are  re-
lated  to  over-expression  of  MMP-2.  This  supported  our  hy-
pothesis  about  over-expression  of  MMPs  and  TIMP  in  VV 
because  the  duration  of  the  symptoms  or  the  awareness  of 
protruded veins was present for at least one year in all of the 
patients  who  were  included.  It  was  speculated  that  this  study 
would  show  a  significant  relationship  between  the  over-ex-
pression  of  MMPs  or  TIMP  and  clinical  characteristics  such 
as  duration  of  symptoms  or  grade  of  reflux  on  duplex 
ultrasonography.  However,  the  results  of  this  study  did  not 
show  any  relationships  between  the  degree  of  expression  of 
MMPs  and  clinical  characteristics.  The  expression  patterns  of 
M M P s  a n d  T I M P  b e t w e e n  t h e  t w o  g r o u p s  w e r e  q u i t e  c o n -
trary to the initial hypothesis (The fact that the control group 
consisted  of  upper  extremity  veins  may  not  have  had  an  ef-
fect  on  the  results  because  they  had  not  been  exposed  to  the Expression of MMP-2 and 13 and TIMP-4 in Varicose Veins
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effects  of  gravity  or  venous  hypertension.).  Reasons  for  such 
results  could  be  assumed  to  be  as  follows.  First,  observing 
the  degree  of  reflux  on  the  duplex  ultrasonography  was  not 
the  proper  method  for  measuring  the  stimulatory  effect  that 
causes  an  increase  in  expression  of  MMPs.  Ishikawa  et  al. 
[7]  reported  that  levels  of  expression  of  MMP-2  and  TIMPs 
in  varicose  veins  were  not  different  from  those  in  the  corre-
sponding  normal  vessels  and  shear  stress  or  increased  intra-
vascular  pressure  may  lead  to  vascular  wall  remodeling.  The 
degree of reflux can be subjective and may  not  properly  rep-
resent  hemodynamic  stress.  Second,  the  effect  of  prolonged 
exposure  to  venous  hypertension  in  vivo  on  changes  in  the 
venous  wall  remains  to  be  clarified.  Raffetto  and  colleagues 
[6]  suggested  that  increased  venous  wall  tension  causes 
over-expression  of  MMPs  and  consequently  promotes  degra-
dation  of  the  extracellular  matrix,  but  they  also  mentioned 
that  in  vitro  tension  time  was  24  hours  in  their  experiment, 
and  whether  or  not  time-dependent  acute  venodilatory  effects 
of  MMPs  have  prolonged  effect  in  vivo  should  be  inve-
stigated.
The  decrease,  lack  of  change,  or  regional  variation  of 
MMP-2  or  MMP-13  in  varicose  veins  has  also  been  pre-
viously noted [8,9]. MMPs are zinc-dependent endopeptidases 
that degrade all kinds of extracellular matrix and process bio-
active  molecules.  Grouping  or  subtyping  MMPs  is  based  on 
the substrate specificity and cellular localization, but it is dif-
ficult to clearly classify the subtypes because the substrates or 
locations  of  MMPs  overlap.  Likewise,  the  precise  role  of 
each MMP subtype during the pathogenesis of VV remains to 
be  clarified. 
CONCLUSION
MMP-2,  13,  and  TIMP-4  did  not  show  significantly  in-
creased  expression  in  VV  when  compared  to  the  control 
group. Clinical characteristics such as degree of reflux on du-
plex  ultrasonography  or  duration  of  symptoms  were  not  sig-
nificantly  related  to  the  increased  expression  of  MMP-13. 
Further  studies  should  be  performed  to  investigate  the  rela-
tionship  between  the  clinical  characteristics  related  to  venous 
hypertension  or  reflux  and  the  expression  of  MMPs  and 
TIMP  in  VV. 
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